A new randomized trial from North Carolina suggests that digital tools like mPATH may slightly boost participation in CT lung cancer screening—yet the overall uptake remains strikingly low. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback